✦ LIBER ✦

The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones

✍ Scribed by T E Miettinen; S Tarpila; H Gylling

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 195 KB
Volume: 25
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510250302

No coin nor oath required. For personal study only.

✦ Synopsis

Lipid Analysis. Serum cholesterol and triglyceride levels were decholesterol. [7][8][9][10][11][12] The latter should result in a compensatory termined using standard hospital laboratory methods. 23,24 Serum free and esterified methylated cholesterol precursor sterols lanosterol, D 8,24 -dimethylsterol (D 8,24 -DMS), D 8 -DMS, D 8 -monomethylsterol (MMS), and methostenol (MS); the demethylated precursor sterols D 8 -lathosterol, lathosterol, and desmosterol; and plant sterols Abbreviations: UDCA, ursodeoxycholic acid; CDCA, chenodeoxycholic acid; DMS, dimethylsterol; MMS, monomethylsterol; MS, methostenol; GLC, gas-liquid chromatography.

campesterol and sitosterol were separated first with 0.2-mm-thick

📜 SIMILAR VOLUMES

Cholesterol metabolism and serum and bil

Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments

✍ Tatu E. Miettinen; Tuula Kiviluoto; Matti Taavitsainen; Matti Vuoristo; Tatu A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Effects of long-term high-dose ursodeoxycholic acid (UDCA) and simvastatin treatments on cholesterol metabolism and biliary lipid compositions were compared in patients with cholesterol gallstones. Absorption and synthesis of cholesterol, serum and biliary noncholesterol sterols and lipids were dete

Effect of pretransplantation ursodeoxych

Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis

✍ Heathcote, E. Jenny ;Stone, Julie ;Cauch-Dudek, Karen ;Poupon, Raoul ;Chazouille 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 42 KB 👁 1 views

As ursodeoxycholic acid (UDCA) delays the need for transplantation, this could result in patients with more comorbid disease, therefore more likely to have a worse outcome posttransplantation. The aim of this study is to compare posttransplantation outcome in patients who received UDCA versus placeb

Clinical significance of serum bilirubin

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

✍ Anne-Marie Bonnand; E. Jenny Heathcote; Keith D. Lindor; Renée Eugénie Poupon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Progesterone metabolites and bile acids

Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapy

✍ L Meng; H Reyes; M Axelson; J Palma; I Hernandez; J Ribalta; J Sjovall 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

The concentrations in serum of sulfated metabolites of pro-Intrahepatic cholestasis of pregnancy (ICP) is charactergesterone are known to be elevated in patients with intraheized by skin pruritus appearing in late pregnancy, coinciding patic cholestasis of pregnancy (ICP). The profiles of these with

Oral budesonide in the treatment of pati

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid

Differences in the metabolism and dispos

Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis

✍ Pietro Invernizzi; Kenneth D. Setchell; Andrea Crosignani; Pier Maria Battezzati 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

The clinical effectiveness of ursodeoxycholate in the treatment of liver disease may be limited by its poor absorption and extensive biotransformation. Because in vitro and in vivo studies suggest that the more hydrophilic bile acid tauroursodeoxycholate has greater beneficial effects than ursodeoxy